Tradestie Institutional Equity Comparison Engine

SCNX vs COOT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SCNX Overall Edge

SCNX Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Scienture Holdings, Inc. Common Stock (SCNX) driven by superior Valuation, Growth & Margin, Momentum & Technical while COOT counters with relative strength in Options & Structure. Fundamentally, SCNX trades at 21.8x Forward P/E with -1671.1% operating margin (+449.1% YoY revenue) versus COOT at N/M Forward P/E and -73.3% operating margin (+9.8% YoY). In options structure, SCNX sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against COOT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SCNX
SCNX 21.8x vs COOT N/M Fwd P/E
Growth & Margin Winner SCNX
Op Margin -1671.1% vs -73.3% ยท YoY +449.1% vs +9.8%
Momentum & Technical Winner SCNX
1Y +287.7% vs -67.7% ยท 52W Pos 56% vs 11%
Options & Structure Winner COOT
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
SCNX NASDAQ
Scienture Holdings, Inc. Common Stock
Pharmaceutical Preparations
$2.44
-4.51% 1D
Market Cap $4.6M
1M Return -16.18%
1Y Return +287.74%
Forward P/E 21.8x
Unified AI Score
53.2 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 70.0
COOT NASDAQ
Australian Oilseeds Holdings Limited Ordinary Shares
Fats & Oils
$0.34
+21.96% 1D
Market Cap $277.8M
1M Return -21.21%
1Y Return -67.73%
Forward P/E N/M
Unified AI Score
55.5 / 100 HOLD
Tech 65.0 Fund 60.0 Flow 50.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SCNX +287.74% COOT -67.73% Spread: +355.47 pp (SCNX Lead)

Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SCNX Revenue COOT Revenue SCNX Op. Margin COOT Op. Margin Margin Edge
Q4 '24 N/A $40M N/A 0.1% COOT
Q1 '25 N/A $40M N/A -1.4% COOT
Q3 '25 $0M N/A -739.1% N/A SCNX
Q1 '26 $0M N/A -6230.8% N/A SCNX
Q2 '26 $0M N/A -785.6% N/A SCNX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SCNX (6) vs COOT (3)
Institutional Metric SCNX COOT Criterion Row Winner
Market Capitalization Scale $4.6M $277.8M Larger Scale COOT
Trailing P/E Ratio Valuation 21.8x N/M Lower Multiple SCNX
Forward P/E Ratio Valuation 21.8x N/M Lower Multiple SCNX
Revenue Growth (YoY) Growth +449.1% +9.8% Higher Growth SCNX
Operating Margin (TTM) Profitability -1671.1% -73.3% Higher Margin COOT
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -53.5% -136.4% Higher ROE SCNX
52-Week Range Position Momentum 56% ($0โ€“$4) 11% ($0โ€“$1) Stronger Trend SCNX
Beta / 30D Volatility Risk Regime 10.87ฮฒ ยท 82% Vol -0.03ฮฒ ยท 118% Vol Lower Realized Risk SCNX
Unified Institutional Score Composite Signal 53.2 / 100 (HOLD) 55.5 / 100 (HOLD) Higher Composite COOT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SCNX vs COOT Buy Guide
SCNX BREAKDOWN
28d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SCNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
COOT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live COOT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SCNX nor COOT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.